These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22879641)

  • 1. Healthcare in Syria is close to collapse as drug shortages bite.
    Pitts-Tucker T
    BMJ; 2012 Aug; 345():e5410. PubMed ID: 22879641
    [No Abstract]   [Full Text] [Related]  

  • 2. US drug shortages are set to reach record high in 2011, report says.
    Tanne JH
    BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
    [No Abstract]   [Full Text] [Related]  

  • 3. National drug shortages.
    Inglis T
    Am J Nurs; 2002 Jul; 102(7):11. PubMed ID: 12394049
    [No Abstract]   [Full Text] [Related]  

  • 4. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
    Noah L
    S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Care Tax Inversions--Robbing Both Peter and Paul.
    Warraich HJ; Schulman KA
    N Engl J Med; 2016 Mar; 374(11):1005-7. PubMed ID: 26981932
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laqueur and organon: the university laboratory and the pharmaceutical industry in the Netherlands].
    Oudshoorn N
    Tijdschr Geschied Geneeskd Natuurwet Wiskd Tech; 1999; 22(1):12-22. PubMed ID: 20677414
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug shortages: causes and cautions.
    Mullins TD; Cook AM
    Orthopedics; 2011 Sep; 34(9):712-4. PubMed ID: 21899237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What can Johnson & Johnson do to remain a giant in the health care industry?
    Carter T
    J Hosp Mark Public Relations; 2002; 14(1):93-103. PubMed ID: 12569997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceutical process development - shortcut to market: an interview with Rolf Werner from Boehringer Ingelheim.
    Jungbauer A; Göbel U
    Biotechnol J; 2012 Jan; 7(1):14-6. PubMed ID: 22228694
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry sponsored bias in cost effectiveness analyses.
    John-Baptiste A; Bell C
    BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724
    [No Abstract]   [Full Text] [Related]  

  • 12. Medication shortages threaten cancer care: the oncology community and the FDA tackle ongoing drug shortage problem.
    Printz C
    Cancer; 2012 Jan; 118(2):289-91. PubMed ID: 22222939
    [No Abstract]   [Full Text] [Related]  

  • 13. Market watch: industry perspectives on personalized medicine.
    Zuckerman R; Milne CP
    Nat Rev Drug Discov; 2012 Mar; 11(3):178. PubMed ID: 22378258
    [No Abstract]   [Full Text] [Related]  

  • 14. [Troubling shortage of drugs].
    Kiefer B
    Rev Med Suisse; 2012 May; 8(342):1144. PubMed ID: 22734188
    [No Abstract]   [Full Text] [Related]  

  • 15. In vogue with venture.
    Patou G
    Nat Biotechnol; 2011 Nov; 29(11):967-9. PubMed ID: 22175076
    [No Abstract]   [Full Text] [Related]  

  • 16. Winners and losers. Corporate tax overhaul would have very different effects for various healthcare sectors.
    Kutscher B
    Mod Healthc; 2013 Apr; 43(15):6-7, 1. PubMed ID: 23741756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industry spending on continuing medical education in US falls further.
    Roehr B
    BMJ; 2012 Aug; 345():e5336. PubMed ID: 22872716
    [No Abstract]   [Full Text] [Related]  

  • 18. It is not unethical, though it is often unwise, to override patents.
    Leventer H
    Am J Bioeth; 2002; 2(3):50-1. PubMed ID: 12230860
    [No Abstract]   [Full Text] [Related]  

  • 19. Current and future state of FDA-CMS parallel reviews.
    Messner DA; Tunis SR
    Clin Pharmacol Ther; 2012 Mar; 91(3):383-5. PubMed ID: 22343814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comments on the editorial "The health sector and the perpetual murkiness in the relations between the medical profession and the drug industry" ].
    Oteo Ochoa LA
    Rev Calid Asist; 2009 Aug; 24(4):178-81. PubMed ID: 19647681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.